+
Site Tour

Search

Showing 101 - 110 of 447 results.

  • Medical Management

    Topilsky Y, Maltais S, Medina Inojosa J et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–442.…
  • Diagnosis

    Most early-stage TR is clinically silent,1 and even with severe TR, some patients may be asymptomatic.27 In patients who become symptomatic of TR, the prevalence and severity of the symptoms are…
  • Guidelines

    Summary of current relevant international guidelines on the diagnosis of TR 0 TR should be evaluated first by echocardiography. In primary TR, specific abnormalities of the valve can be…
  • Overview

    Secondary TR arising from RV remodelling can be classified in three progressive stages26 0 Initial Right Ventricular (RV) dilatation results in Tricuspid Annulus (TA) dilatation 0 Progressive…
  • Overview

    See Diagnosis 0 AS is a progressive disease. While patients with AS may initially be asymptomatic, further progression is typically associated with symptoms and poor prognosis.13,14 AS is…
  • Diagnosis

    The three cardinal symptoms of AS are angina, syncope or heart failure (HF).13,16 Other symptoms include dyspnea and decreased exercise tolerance.14 0 Primary care physicians should consider AS in…
  • Options

    Treatment options for aortic stenosis: MEDICAL MANAGEMENT Medical treatment options for symptomatic patients with severe AS are limited. Medical treatment may be helpful in ameliorating symptoms in…
  • Surgical Replacement

    FIND OUT MORE: Abbott Tissue Heart Valves   Abbott Mechanical Heart Valves 0
  • Guidelines

    Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). …
  • Overview

    Two Types of Mitral Regurgitation 0 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline